Pharmaceutical packaging can induce confusionBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7338.679/a (Published 16 March 2002) Cite this as: BMJ 2002;324:679
- Michael Rigby (firstname.lastname@example.org), senior lecturer
- Centre for Health Planning and Management, Keele University, Keele, Staffordshire ST5 5BG
EDITOR—The pharmaceutical industry seems to be dominated by packaging initiatives that unnecessarily compromise patient compliance and thus safety. A middle aged male patient in Ireland reports the challenge he faces daily as a result of inventiveness in product presentation. Currently he is prescribed six not unusual medications for a hypertensive condition and related effects, one replacing a previous drug. The packaging of each is in blister packs, one tablet to be taken per day, but the total non-standardisation of presentation is shown in the table.